Wall Street's Most Accurate Analysts Give Their Take On 3 Financial Stocks Delivering High-Dividend Yields

Route 92 Medical Enters Into Financing Facility with Trinity Capital

Route 92 Medical has entered into a new financing facility with Trinity Capital Inc. to support its ongoing growth and product demand.

Route 92 Medical Announces $100 Million Corporate Debt Facility

Route 92 Medical, a neurovascular medical technology company, secured a $100 million senior secured debt facility from Trinity Capital Inc. to support its growth strategy and meet strong product demand. The company's integrated neurovascular platform features proprietary technologies including Tenzing delivery catheters and Monopoint, with products like HiPoint 88 receiving FDA clearance for acute ischemic stroke treatment.

Trinity Capital Originated $880M Of New Commitments In The Third Quarter Of 2026, Bringing New Commitments For The First Three Quarters Of 2026 To $2.0B

Walker & Dunlop Advises on Broe Real Estate Group's Acquisition of 525 Olive

Walker & Dunlop's Hunter Combs served as an advisor for the Broe Real Estate Group's acquisition of 525 Olive, a 204-unit luxury apartment community in San Diego.

Walker & Dunlop Executes $151 Million in Financing via HUD's 'LEAN Express Lane' Program

Walker & Dunlop has utilized the U.S. Department of Housing and Urban Development's (HUD) new 'LEAN Express Lane' program to facilitate $151 million in financing.

Citizens Maintains Market Outperform on Walker & Dunlop, Lowers Price Target to $50

Citizens analyst Chris Muller maintains Walker & Dunlop (NYSE:WD) with a Market Outperform and lowers the price target from $55 to $50.